Clinical Trial Update: Gonadotropin-releasing Hormone (GnRH) Antagonist During 3 Days [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a gonadotropin-releasing hormone antagonist over a 3-day course for infertility has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• GnRH antagonist

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Infertility | Phase 4 | Status: COMPLETED